AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first IL-23 inhibitor indicated for both major types of inflammatory bowel disease (IBD) – UC and ...
Ruby is your Delano and McFarland Neighborhood Reporter! Ruby Rivera is a bilingual reporter who joined the team in December of 2022. She graduated from California State University, Northridge with a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果